**Author details**

Dinara Sadykova1,2\*, Liliia Galimova2 , Evgeniia Slastnikova<sup>2</sup> , Zulfiia Khabibrakhmanova1 and Natalya Guseva2

1 Kazan State Medical University, Kazan, Russian Federation

2 Kazan State Medical University, Children's Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, Kazan, Russian Federation

\*Address all correspondence to: sadykovadi@mail.ru

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**105**

*Arterial Stiffness Assessment in Children with Familial Hypercholesterolemia*

[6] Pećin I., Hartgers M.L.,

in patients with familial

Hovingh G.K., Dent R., Reineret Z. Prevention of cardiovascular disease

hypercholesterolaemia: the role of PCSK9 inhibitors. Eur J Prev Cardiol 2017; 24: 1383-1401. http://dx.doi. org/10.1177/2047487317717346.

[7] Yezhov MV, Bliznyuk SA, Tmoyan NA, Rozhkova DV, Duplyakov VA, Salchenko MA. et al. Register of patients with familial hypercholesterolemia and patients of very high cardiovascular risk with lipidlowering therapy underperformance (RENESSANS). Russian Journal of Cardiology.2019; (5):7-13. [In Russian] doi:10.15829/1560-4071-2019-5-7-13.

[8] Vallejo-Vaz A.J., Akram A., Cole D., Watts G.F., Hovingh G.K. et al. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration. Atheroscler Suppl 2016; 22: 1-32. doi: 10.1016/j. atherosclerosissup.2016.10.001.

[9] Watts G., Gidding S., Wierzbicki A., Toth PP, Alonso R., Brown WV et al. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Inter J Cardiol 2014; 171:309-325:10. doi:

[10] Reiner Ž. Management of patients with familial hypercholesterolaemia. Nat Rev Cardiol 2015; 12: 565-575. doi:

[11] Migliara, G., Baccolini, V., Rosso, A., D'Andrea E., Massimi A.,Villari P. et al. Familial Hypercholesterolemia: A Systematic Review of Guidelines on Genetic Testing and Patient Management. Frontiers in Public

1016/j.ijcard.2013.11.025.

10.1038/nrcardio.2015.92.

*DOI: http://dx.doi.org/10.5772/intechopen.96018*

[1] Clinical guidelines. Familial hypercholesterolemia. 2018. Available

from: https://noatero.ru/sites/ default/files/proekt\_klinicheskie\_ rekomendacii\_sghs\_mz\_rf\_18.01.pdf.

[2] Borén J., Chapman M. J., Krauss R. M., Packard C. J., Bentzon J. F., Binder C. et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal. 2020; 0, 1-28. doi:10.1093/eurheartj/ehz962.

[3] Mach F., Baigent C., Catapano A. L., Koskinas K. C., Casula M., Badimon L. et al. ESC Scientific Document Group, 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS), European Heart Journal; 2020; 41 (1): 111-188. doi.org/10.1093/

[Accessed: 2020-12-08]

**References**

eurheartj/ehz455.

[4] De Backer G, Besseling J, Chapman JG, Hovingh GK,

and management of familial hypercholesterolaemia in coronary patients: an analysis of EUROASPIRE IV, a study of the European Society of Cardiology. Atherosclerosis 2015; 241: 169-175. doi: 10.1016/j. atherosclerosis.2015.04.809.

[5] Vallejo-Vaz AJ, Kondapally Seshasai SR, Cole D, Hovingh GK, Kastelein JJ, Mata P et al. Familial hypercholesterolaemia: a global call to arms. Atherosclerosis 2015; 243: 257-259. doi: 10.1016/j. atherosclerosis.2015.09.021.

Kastelein JJ, Kotseva K et al. Prevalence

*Arterial Stiffness Assessment in Children with Familial Hypercholesterolemia DOI: http://dx.doi.org/10.5772/intechopen.96018*
